"Memantine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.
| Descriptor ID |
D008559
|
| MeSH Number(s) |
D02.455.426.100.050.035.500
|
| Concept/Terms |
Memantine- Memantine
- Memantin
- 1,3-Dimethyl-5-aminoadamantane
- 1-Amino-3,5-dimethyladamantane
|
Below are MeSH descriptors whose meaning is more general than "Memantine".
Below are MeSH descriptors whose meaning is more specific than "Memantine".
This graph shows the total number of publications written about "Memantine" by people in this website by year, and whether "Memantine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Memantine" by people in Profiles.
-
[Anti-inflammatory effects of amantadine and memantine in SARS-CoV-2 infection]. Pol Merkur Lekarski. 2021 Feb 24; 49(289):67-70.
-
SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine. Rom J Morphol Embryol. 2020 Oct-Dec; 61(4):1007-1022.
-
Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond. Eur Respir J. 2020 08; 56(2).
-
A retrospective review of memantine use and COVID-19-associated mortality from a national database. J Med Virol. 2021 01; 93(1):168-169.
-
SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine. Biochem Biophys Res Commun. 2020 09 10; 530(1):10-14.
-
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects. J Med Virol. 2020 11; 92(11):2341-2342.
-
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment. Mult Scler Relat Disord. 2020 Jul; 42:102163.
-
One-Year Persistence with Donepezil, Memantine, and Rivastigmine in More than 66,000 Elderly Patients Followed in Poland. J Alzheimers Dis. 2019; 70(3):899-905.
-
Monotherapy Is Good Enough for Patients with Mild-to-Moderate Alzheimer's Disease: A Network Meta-analysis of 76 Randomized Controlled Trials. Clin Pharmacol Ther. 2019 01; 105(1):121-130.
-
Fibromyalgia and bipolar disorder: extent of comorbidity and therapeutic implications. J Biol Regul Homeost Agents. 2017 Jan-Mar; 31(1):17-20.